Craig Johnson - Dec 21, 2021 Form 4 Insider Report for HERON THERAPEUTICS, INC. /DE/ (HRTX)

Role
Director
Signature
/s/ Lisa Peraza Attorney-in-fact for Craig A. Johnson
Stock symbol
HRTX
Transactions as of
Dec 21, 2021
Transactions value $
-$2,432
Form type
4
Date filed
12/23/2021, 05:57 PM
Previous filing
Sep 23, 2021
Next filing
Jan 14, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HRTX Common Stock Sale -$2.43K -250 -8.09% $9.73 2.84K Dec 21, 2021 Direct F1, F2
transaction HRTX Common Stock Award $0 +10.5K +368.03% $0.00 13.3K Dec 22, 2021 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HRTX Stock Option (Right to Buy) Award $0 +20.9K $0.00 20.9K Dec 22, 2021 Common Stock 20.9K $9.81 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan dated as of March 3, 2021. The shares were sold by Mr. Johnson to cover his estimated tax liability associated with the vesting of 750 restricted stock units (RSUs) on December 21, 2021.
F2 The range of sales prices received was $9.625 to $9.845. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price.
F3 The shares were granted as restricted stock units which vest in full on December 22, 2022.
F4 The stock options vest and become exercisable in 12 equal monthly installments beginning one month after the date of grant.